Domingo Andrés Pascual Figal


Rossignol P, Lainscak M, Crespo-Leiro MG, Laroche C, Piepoli MF, Filippatos G, Rosano GMC, Savarese G, Anker SD, Seferovic PM, Ruschitzka F, Coats AJS, Mebazaa A, McDonagh T, Sahuquillo A, Penco M, Maggioni AP, Lund LH; Heart Failure Long-Term Registry Investigators Group. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry. Eur J Heart Fail. 2020 Apr 3. doi: 10.1002/ejhf.1793. [Epub ahead of print] PubMed PMID: 32243669.
AÑO: 2020; IF: 13.965
Revuelta-López E, Lupón J, Lax A, Pascual-Figal DA, Bayés-Genís A. Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure. J Cardiovasc Transl Res. 2020 Jan 22. doi: 10.1007/s12265-020-09958-7. [Epub ahead of print] PubMed PMID: 31970669.
AÑO: 2020; IF: 2.756
Asensio Lopez MDC, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes Genis A, Pascual Figal DA. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Aug 11;10(1):13553. doi: 10.1038/s41598-020-70454-8. PubMed PMID: 32782412; PubMed Central PMCID: PMC7419540.
AÑO: 2020; IF: 3.998
Escobar C, Barrios V, Cortés CO, Sales JC, Pascual Figal DA, Marimón XG. Recommendations to improve the management and the prognosis of patients with heart failure. Future Cardiol. 2020 Jan;16(1):1-4. doi: 10.2217/fca-2019-0042. Epub 2019 Nov 25. PubMed PMID: 31762325.
AÑO: 2020
Vicent L, Alvarez-Garcia J, Gonzalez-Juanatey JR, Rivera M, Segovia J, Worner F, Bover R, Pascual-Figal D, Vázquez R, Cinca J, Fernandez-Aviles F, Martinez-Sellés M. Prognostic impact of hyponatremia and hypernatremia at admission and discharge in heart failure patients with preserved, mid-range, and reduced ejection fraction. Intern Med J. 2020 Apr 1. doi: 10.1111/imj.14836. [Epub ahead of print] PubMed PMID: 32237007.
AÑO: 2020; IF: 1.767

Instituto de Investigación Sanitaria Acreditado